Back to today’s briefing

Story perspectives

Study Reveals Drug Sensitivity in Endometrial Cancer Organoids

10/28/2025

37 6

Summary

Story summary

A study on endometrial cancer drug sensitivity used organoids to screen responses.
Researchers dissociated organoids into single cells and seeded 1,000 cells per well in 96-well plates.
They treated cells with seven drug concentrations from 10–4 to 102 uM, with DMSO as a control.
After 48 hours, they added CellTiter-Glo 2.0 to measure viability by ATP.
They measured luminescence with a microplate reader and normalized results to controls.

1 of 1

Story summary

A study on endometrial cancer drug sensitivity used organoids to screen responses.
Researchers dissociated organoids into single cells and seeded 1,000 cells per well in 96-well plates.
They treated cells with seven drug concentrations from 10–4 to 102 uM, with DMSO as a control.
After 48 hours, they added CellTiter-Glo 2.0 to measure viability by ATP.
They measured luminescence with a microplate reader and normalized results to controls.